[Clinicobiochemical parallels in borderline neuropsychic disorders].
Under examination there were 173 patients with borderline neuropsychic disorders of the neurotic and neurosis-like genesis. In the course of the treatment the levels of acetylcholine and catecholamines were determined. It has been shown that in borderline neuropsychic disorders there are statistically significant differences in the levels of those neuromediators, these differences being characteristic for the neurotic and neurosis-like disorders. The process of the normalization of those levels was found to depend on the initial changes, which, in their turn, depended on the etiopathogenesis of the borderline disorders.
D000328:Adult; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007046:Hysteria / Q000097:blood / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000097:blood* / Q000188:drug therapy; D018377:Neurotransmitter Agents / Q000097:blood; D013997:Time Factors
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D018377:Neurotransmitter Agents; D001569:Benzodiazepines; C017928:phenazepam
Kliniko-biokhimicheskie paralleli pri pogranichnykh nervno-psikhicheskikh rasstroĭstvakh.